Cancer patients with dementia less likely to achieve a 'good death'

Cancer patients with dementia less likely to achieve a 'good death'

As the population ages, the number of cancer patients with dementia has increased. A recent study published in Geriatrics & Gerontology International found that cancer patients with dementia were less likely to achieve a "good death" than those without. In the study, quality of death was measured from nurses' reports and factored in life completion, place of death, and symptom management. Of the 508 patients with cancer in the study, 156 (30.7%) had dementia. Dementia was associated with a reduced quality of death among patients. The study's authors note that it may be difficult to confirm patients' end-of-life preferences because of cognitive decline. Their findings point to the importance of enhancing end-of-life care discussions with patients and their families. In order to provide high quality of end-of-life care, we should facilitate end-of-life care discussions and improve symptom management especially for cancer patients with dementia." Kayo Hirooka, RN, PhD, lead author, Keio University, in Japan Source: Wiley Journal reference: Hirooka, K., et al. (2020) Impact of dementia on quality of death among cancer patients: An observational study of home palliative care users. Geriatrics & Gerontology International. doi.org/10.1111/ggi.13860 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More